91PDRaman microscopy for the identification of an aggressive variant of prostate cancer, intraductal carcinoma of the prostate

ConclusionsAs clinically available biomarkers of IDC have reported sensitivities/specificities of ∼80%, we here identified IDC with accuracies ≥85%. Since our classification model was trained on a cohort and independently tested on the other two, these are likely to be close to real life experience making clinical implementation a realistic outcome.Legal entity responsible for the studyThe authors.FundingCentre de Recherche du Centre Hospitalier de l ’Université de Montréal (CRCHUM, continuum program) IVADO, Institut de valorisation des données.DisclosureAll authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Source Type: research